Skip to content

Subcutaneous Lavage in Cesarean Section

Antiseptic Washing Prior to Skin Closure During Cesarean Delivery- a Randomized Control Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06454227
Enrollment
600
Registered
2024-06-12
Start date
2024-09-22
Completion date
2028-12-01
Last updated
2025-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Site Infection

Brief summary

The goal of this clinical trial is to learn if antiseptic washing prior to skin closure during cesarean section reduces rates of surgical site infection. intraoperative washing is a common practice in other surgical fields and several studies have shown efficacy in reducing postoperative infection rates. no randomized control trial has tested this intervention during cesarean section. The main questions we aim to answer are: Does subcutaneous antiseptic washing reduce the rates of surgical site infection? Does antiseptic washing improve scar healing? Does antiseptic washing reduce hospital stay, postpartum fever rates and readmission cases? Researchers will compare subcutaneous antiseptic washing to no intervention to see if surgical site infection rates reduce Participants will: consent to participate in the trial Visit the postpartum clinic 30 days after surgery

Interventions

PROCEDURESubcutaneous washing

subcutaneous washing with chlorhexidine gluconate prior to skin closure

PROCEDUREno subcutaneous washing

no washing

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* pregnant women undergoing cesarean delivery

Exclusion criteria

* pregnant women undergoing vaginal delivery

Design outcomes

Primary

MeasureTime frameDescription
surgical site infection30 days after surgerySSI infection rates

Secondary

MeasureTime frameDescription
hospital stay30 days after surgerylength of hospital stay
wound healing30 days after surgeryassessment of the healing according to Southampton criteria: presence of inflammation, erythema or discharge
postpartum fever30 days after surgeryfever recording

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026